Brainsway
Brainsway is the developer of Deep Transcranial Magnetic Stimulation (TMS) Therapy, a patented, noninvasive, FDA-cleared solution for treating depressive episodes in adult patients suffering from major depressive disorder who have failed to achieve s.
Launch date
Employees
Market cap
$128m
Enterprise valuation
$83m (Public information from Sep 2024)
Share price
$8.4 BWAY
Burlington Massachusetts (HQ)
Authorizing premium user...